Literature DB >> 10024677

Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.

T Hisaka1, H Yano, M Haramaki, I Utsunomiya, M Kojiro.   

Abstract

In 6 HCC cell lines, clear expressions of EGFR and TGF-alpha were found in flow cytometry, while expressions of EGF, HB-EGF and AR were quite low. TGF-alpha secretion into culture supernatants became measurable when TPA 0.5 microM was added. TPA accelerated the proliferation of KYN-3 cells, and anti-TGF-alpha neutralizing antibody suppressed this proliferation in a dose-dependent manner. Addition of exogenous TGF-alpha, EGF, AR, or HB-EGF with heparin accelerated cell proliferation. In non-stimulated cultures, cell proliferation was suppressed by anti-EGFR neutralizing antibody, but not by the antibodies for EGF, TGF-alpha, AR and HB-EGF. HCC may possess a paracrine system regulated by these 4 ligands, and an autocrine system, under a certain condition, via TGF-alpha and EGFR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024677     DOI: 10.3892/ijo.14.3.453

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  18 in total

1.  Liver cancer: Targeted future options.

Authors:  Andreas Pircher; Michael Medinger; Joachim Drevs
Journal:  World J Hepatol       Date:  2011-02-27

2.  Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Melanie B Thomas; Deborah Jaffe; Michael M Choti; Jacques Belghiti; Steven Curley; Yuman Fong; Gregory Gores; Robert Kerlan; Phillipe Merle; Bert O'Neil; Ronnie Poon; Lawrence Schwartz; Joel Tepper; Francis Yao; Daniel Haller; Margaret Mooney; Alan Venook
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  NADPH oxidase NOX1 controls autocrine growth of liver tumor cells through up-regulation of the epidermal growth factor receptor pathway.

Authors:  Patricia Sancho; Isabel Fabregat
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

4.  Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.

Authors:  Z W Zhu; H Friess; L Wang; M Abou-Shady; A Zimmermann; A D Lander; M Korc; J Kleeff; M W Büchler
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells.

Authors:  Jun-Ichi Okano; Kazuya Matsumoto; Takakazu Nagahara; Yoshikazu Murawaki
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

6.  Current approach in the treatment of hepatocellular carcinoma.

Authors:  Luigi Rossi; Federica Zoratto; Anselmo Papa; Francesca Iodice; Marina Minozzi; Luigi Frati; Silverio Tomao
Journal:  World J Gastrointest Oncol       Date:  2010-09-15

7.  Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection.

Authors:  Q Wang; Z Y Lin; X L Feng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

8.  Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells.

Authors:  Bin-Wen Wu; Yuan Wu; Jia-Long Wang; Ju-Sheng Lin; Shu-Yu Yuan; Ai Li; Wu-Ren Cui
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 9.  Molecular targeted therapy for hepatocellular carcinoma.

Authors:  Melanie Thomas
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

10.  ADAM17 mRNA expression and pathological features of hepatocellular carcinoma.

Authors:  Xiang Ding; Lian-Yue Yang; Gen-Wen Huang; Wei Wang; Wei-Qun Lu
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.